Teleflex | TFX - Sales Revenues

Stock Price
123.84
Daily Change
-9.46 -7.10%
Monthly
3.54%
Yearly
-2.16%
Q2 Forecast
133.64

Teleflex reported $568.98M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Align Technology USD 1.04B 10M Mar/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
Dexcom USD 1.19B 70M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Orthofix International USD 219.91M 14.28M Dec/2025
ResMed USD 1.4B 0 Mar/2026
Steris USD 1.5B 470M Dec/2025
Stryker USD 6B 1.2B Mar/2026
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026